Vista Pharmaceuticals Ltd. - Research Center
524711 VISTAPH Group (Z) BSE data
Add to watchlist
| Results | |
| Statement | |
| More |
Capital structures
|
Capital structure
(Rs crore)
| From Year | To Year | Class Of Share | Authorized Capital | Issued Capital | Paid Up Shares (Nos) | Paid Up Face Value | Paid Up Capital |
|---|---|---|---|---|---|---|---|
| 2022 | 2023 | Equity Share | 15.00 | 7.51 | 37556639 | 2 | 7.51 |
| 2021 | 2022 | Equity Share | 15.00 | 7.36 | 36793907 | 2 | 7.36 |
| 2020 | 2021 | Equity Share | 15.00 | 7.36 | 36793907 | 2 | 7.36 |
| 2019 | 2020 | Equity Share | 15.00 | 6.07 | 30365337 | 2 | 6.07 |
| 2017 | 2018 | Equity Share | 15.00 | 5.83 | 29147192 | 2 | 5.83 |
| 2016 | 2017 | Equity Share | 15.00 | 5.31 | 26571286 | 2 | 5.31 |
| 2015 | 2016 | Equity Share | 15.00 | 5.00 | 25000000 | 2 | 5.00 |
| 2014 | 2015 | Equity Share | 15.00 | 5.00 | 25000000 | 2 | 5.00 |
| 2013 | 2014 | Equity Share | 15.00 | 15.00 | 15000000 | 10 | 15.00 |
| 2012 | 2013 | Equity Share | 15.00 | 15.00 | 15000000 | 10 | 15.00 |
| 2011 | 2012 | Equity Share | 15.00 | 15.00 | 15000000 | 10 | 15.00 |
| 2010 | 2011 | Equity Share | 15.00 | 15.00 | 15000000 | 10 | 15.00 |
| 2009 | 2010 | Equity Share | 15.00 | 15.00 | 15000000 | 10 | 15.00 |
| 2008 | 2009 | Equity Share | 15.00 | 15.00 | 15000000 | 10 | 15.00 |
| 2007 | 2008 | Equity Share | 15.00 | 10.73 | 10728606 | 10 | 10.73 |
| 2006 | 2007 | Equity Share | 11.50 | 10.73 | 10728606 | 10 | 10.73 |
| 2005 | 2006 | Equity Share | 11.50 | 10.73 | 10728605 | 10 | 10.73 |
| 2004 | 2005 | Equity Share | 10.00 | 7.24 | 7242189 | 10 | 7.24 |
| 2003 | 2004 | Equity Share | 10.00 | 6.96 | 6957940 | 10 | 6.96 |
| 2001 | 2003 | Equity Share | 8.00 | 6.71 | 6705238 | 10 | 6.71 |
| 1999 | 2000 | Equity Share | 8.00 | 6.71 | 6705238 | 10 | 6.71 |
| 1998 | 1999 | Equity Share | 8.00 | 6.71 | 6705238 | 10 | 6.71 |
| 1994 | 1998 | Equity Share | 7.00 | 6.26 | 6259400 | 10 | 6.26 |
| 1993 | 1994 | Equity Share | 2.50 | 2.05 | 2050000 | 10 | 2.05 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis